Silicon Laboratories (NASDAQ:SLAB – Get Free Report) issued an update on its fourth quarter earnings guidance on Monday morning. The company provided earnings per share guidance of ($0.21)-($0.01) for the period, compared to the consensus earnings per share estimate of $0.13. The company issued revenue guidance of $161-$171 million, compared to the consensus revenue estimate of $187.40 million. Silicon Laboratories also updated its Q4 2024 guidance to -0.210–0.010 EPS.
Analyst Upgrades and Downgrades
SLAB has been the subject of a number of research reports. KeyCorp dropped their target price on shares of Silicon Laboratories from $150.00 to $115.00 and set an “overweight” rating for the company in a report on Tuesday. Barclays cut their price objective on shares of Silicon Laboratories from $120.00 to $75.00 and set an “equal weight” rating for the company in a report on Tuesday. JPMorgan Chase & Co. lowered their target price on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating on the stock in a report on Tuesday. Needham & Company LLC reiterated a “buy” rating and set a $150.00 price objective on shares of Silicon Laboratories in a research report on Thursday, July 25th. Finally, StockNews.com upgraded Silicon Laboratories to a “sell” rating in a report on Wednesday, October 30th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $121.50.
Check Out Our Latest Stock Analysis on SLAB
Silicon Laboratories Stock Performance
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.07. The firm had revenue of $166.00 million for the quarter, compared to the consensus estimate of $165.50 million. Silicon Laboratories had a negative return on equity of 12.40% and a negative net margin of 46.93%. The company’s quarterly revenue was down 18.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.48 EPS. As a group, equities analysts predict that Silicon Laboratories will post -3.41 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, SVP Brandon Tolany sold 845 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $115.00, for a total transaction of $97,175.00. Following the completion of the transaction, the senior vice president now directly owns 43,615 shares of the company’s stock, valued at approximately $5,015,725. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.72% of the company’s stock.
Silicon Laboratories Company Profile
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
See Also
- Five stocks we like better than Silicon Laboratories
- Trading Stocks: RSI and Why it’s Useful
- What a Trump Win Looks Like for The Market Now and Into 2025
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- What is the Hang Seng index?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.